Neuromuscular + Peripheral Neuropathy Flashcards
(113 cards)
In terms of NMJ conditions, which are pre-synaptic and which are post-synaptic
Presynaptic
- Lambert Eaton Myasthenic Syndrome (voltage gated calcium channel ab)
- Botulism: acetylcholine vesicle
Post synaptic
- Myasthenia gravis: acetylcholine receptors
- Organophosphate poisoning: acetylcholinesterase
Main characteristics of MG
- Post-synaptic antibody mediated disease (T cells)
- Associated with thymoma or thymic hyperplasia
- Ocular symptoms are the most common presenting symptom (diplopia, ptosis)
- Ptosis can be alternating
- Generalised weakness
- Fatigability
What conditions are MG associated with?
- Thymoma
- Thymic hyperplasia
- Hashimoto thyroiditis
- RA
- Sarcoidosis
- SLE
thymomas in 15%
autoimmune disorders: pernicious anaemia, autoimmune thyroid disorders, rheumatoid, SLE
thymic hyperplasia in 50-70%
What are the main clinical forms of MG
- Ocular MG: only the extraocular and/or eyelid muscles
- Generalised MG:
All skeletal muscles may be involved
Especially ocular, bulbar, limb and respiratory muscles - so difficulty standing up, climbing stairs, swallowing or chewing
Medications that should be avoided in MG
- Beta blockers
- Calcium channel blockers (verapamil)
- Aminoglycosides (eg: gentamicin) - especially out of the abx
- Fluoroquinolones (eg: ciprofloxacin)
- Tetracylcines (eg: doxycycline)
- Macrolides (eg: azithromycin)
- Phenytoin
- Lithium
- Magnesium
penicillamine quinidine, procainamide beta-blockers lithium phenytoin antibiotics: gentamicin, macrolides, quinolones, tetracyclines
Clinical features of MG
- Eye muscle weakness: most common initial symptom - ptosis, diplopia, blurred vision
- Bulbar muscle weakness: slurred speech, difficulty chewing and/or swallowing
- Proximal limb weakness: rising from chair, climbing stairs, brushing hair. Deep tendon reflexes not affected
- Resp muscle weakness: dyspnoea
- Muscle fatigability
Antibodies associated in MG
85% of patients have generalised myasthenia
- 85% are acetylcholine receptor (AChR) antibody positive
- 6-10% are muscle specific kinase (MuSK) ab positive
- Small group of seronegative can seroconvert in 1st year
15% of patients have ocular myasthenia
- 50% are ACHR antibody positive
- 66% of patients will progress to generalised within 2 years
- 90% of those who do not generalise within 2 years will remain ocular
(Most people will become generalised but a small subset remain ocular)
- AChR ab correlate with thymoma or thymic hyperplasia
- Antibody titres don’t correlate with clinical severity and no need to conduct follow up serology
- Ocular and generalised
MuSK Ab
- Non white, young, female
- Early onset
- Not related to thymoma/hyperplasia
- Generalised MG
- Severe weakness +/- atrophy
- Severe disease with respiratory and bulbar involvement
- Less fluctuation
- Poor response to treatment, good response to rituximab
LRP4 Ab: mild to mderate disease
MUSK and LRP4 are not associated with thymoma
Titin: late onset, severe thymoma
Titin also associated with myocarditis
Hanna Pearls
Acetylcholine receptor positive in 80% of patients
- 50% would have a thymoma - thymectomy
- 30% have hyperplasia of the thymus - for thymectomy if <55yo
- Can reduce immunotherapy after thymectomy
10-15% patients have MuSK antibody
- Patients do not have a thymoma and do not undergo a thymectomy
Titin Antibodies
- If this is positive, need to check anti-neuronal ab to check for paraneoplastic syndromes
-In patients who are titin ab positive, 100% patients will have a thymoma
Rare: can have seronegative MG so no antibodies
Investigations of MG besides Ab
- Ice Test: An ice pack is applied to the affected upper eyelid for 2-5 minutes. A positive test is the improvement of ptosis by > 2mm or more. This transient improvement in ptosis is due to the cold decreasing the acetylcholinesterase break-down of acetylcholine at the neuromuscular junction.
Single nerve fibre and repetitive nerve stimulation (electrodiagnostics)
- Single Fibre EMG: Best utilised for ocular MG
High sensitivity, low specificity, false positives
Repetitive Stimulation
- Repeated stimulation of nerve
- 10% decrement in amplitude is diagnostic - a smaller and smaller muscle response with each repetitive stimulus) is abnormal and indicates NMJ dysfunction.
- Greater decrement post exercise
- Generalised MG: Sensitivity 80%
- Ocular MG: 20%
Tensilon Test (edrophonium) 70-95% sensitivity
- Administration of edrophonium which is a short acting acetylcholinesterase inhibitor
- IV bolus given along with atropine at bedside (in case of myasthenia gravis)
- Assess if objective change in signs - normally would get better with repeated doses
- Sensitivity 60%, low specificity
- A patient suffering from myasthenia gravis experiences improvement in muscle strength and endurance with repetitive movements, while healthy persons do not feel any difference. The effects of edrophonium lasts around 10 minutes. The edrophonium allows accumulation of acetylcholine (ACh) in the neuromuscular junctions, and makes more ACh available to the muscle receptors, thereby increasing muscle strength in myasthenia gravis.
CT Chest for thymoma
Pathophysiology of MG
Normal:
Acetycholine fuse with the presynaptic membrane –> release of Ach in the synaptic cleft –> reversible binding of ACh to the nicotinic ACh receptor –> opening of receptor ion channel –> influx of ions –> depolarisation action potential and contraction of the muscle –> breakdown of Ach by cholinesterase and reuptake in the motor end plate
In MG
- autoantibodies compete with ACh for postsynatpic AChR –> ACh cannot bind –> receptor ion channel does not open –> no neuromuscular transmission
Treatment for MG
- Thymectomy
- Cholinesterase inhibitors: pyridostigmine (should be avoided in acute resp failure as it can increase resp secretions)
Pyridostigmine is a long-acting acetylcholinesterase inhibitor that reduces the breakdown of acetylcholine in the neuromuscular junction, temporarily improving symptoms of myasthenia gravis - If symptoms persist:
Steroids
Azathioprine: better than pred monotherapy but takes several months to become effective
Mycophenolate, tacrolimus, methotrexate
IVIG, plasma exchange, rituximab in refractory disease
Eculizumab: severe cases (C5 inhibitor)
Efgartigimoid: neonatal Fc receptor (FcRn) molecule that recycle IgG, extending its half life by about 4x that of other immunoglobulins. - For patients with MuSK ab - typically refractory to pyridostigmine, respond well to IVIG and plasmapharesis and rituximab.
Characteristics of myasthenia crisis
- Severe weakness with respiratory weakness/failure
- Causes: infection, surgery, pregnancy, medications (beta blocker, aminoglycosidesm calcium channel blockers, magnesium fluroquinolones)
- Tx; IVIG for 5 days, plasmapheresis, early intubation
Compare myasthenic crisis with cholinergic crisis
Myasthenic Crisis (too little acetylcholine) - mydriasis - Tachycardia - Cold and faint - Normal secretions - No fasciculations Tx: IVIG, plasmapheresis
Cholinergic crisis (too much acetylcholine due to too much cholinesterase inhibitors) - Miosis - Bradycardia - Fasciculations - Warm and flushed skin - Increased bronchial secretions - Abdominal cramps Tx; A cholinergic crisis should be treated by withdrawing all anticholinesterase medication, mechanical ventilation if required, and atropine i.v. for muscarinic effects of the overdose. The neuromuscular block is a nicotinic effect and will be unchanged by atropine.
Characteristics of lambert eaton myasthenic gravis
- Can be both autoimmune and paraneoplastic
- Paraneoplastic normally secondary to SCLC
- Non-neoplastic; HLAB8DR3
- Ab against voltage gated calcium channels, proximal weakness improves with exercise, exercise, dysautonomia
Clinical features of lambert eaton myasthenic gravis
Clinical triad of
- Proximal weakness which improves with exercise
Proximal LL –> proximal UL –> distal muscles –> oculobulbar
- Autonomic features: dry mouth, erectile dysfunction, constipation, urinary issues, orthostatic hypotension
- Areflexia
Ix of lambert eaton myasthenic gravis
- Voltage gated calcium channel ab
- Malignancy screen
- EMG: repetitive nerve stimulation results in incremental response
Tx of lambert eaton MG
- Tumour resection
- Amifampridine (3,4-diaminopyridine): blocks presynaptic potassium channel (blocks efflux of potassium ions) –> increase action potential duration/prolong duration of depolarisation –> increased presynaptic calcium concentrations
- Immunosuppression: IVIG, pred (in non paraneoplastic)
Contrast MG with LEMG
MG
- Associated disease: thymoma
- Starts with weakness of extraocular muscles, proximal weakness worsens with use
- Normal reflexes
- Repetitive nerve stimulation: decremental response
- Autonomic dysfunction: none
- Responds to cholinesterase inhibitors
LEMG
- Associated disease: small cell lung cancer
- Proximal limb muscle weakness that improves throughout the day
- Reduced/absent reflexes
- Repetitive nerve stimulation: incremental response
- Autonomic dysfunction: dry mouth, erectile dysfunction, constipation, urinary issues postural hypotension
- Amifampridine (3,4-diaminopyridine): blocks presynaptic potassium channel (blocks efflux of potassium ions) –> increase action potential duration/prolong duration of depolarisation –> increased presynaptic calcium concentrations
Characteristics of botulism
- Secondary to clostridium botulinum
- Inhibit presynaptic acetylcholine release
Foodborne Botulism
- Ingestion of botulinum toxin
- Incubation mean 2 days
- N+V
- Symmetric descending flaccid paralysis
- Autonomic involvement: dry eyes, dry mouth, paralytic ileus, urinary retention
- Internal and external ophthalmoplegia
Internal: pupillary muscles, dilation of pupil, and fixed
External: paralysis of extraocular muscles - can’t move eyes
If there is internal + external ophthalmoplegia think toxin! - Mentation and reflexes preserved
Mx
- Removal of unabsorbed toxin only considered if ileus present
- Avoid aminogycoside use as death of clostridum leads to more toxin being produced
- Equine antitoxin
Prognosis
- Recovery over months
- Main complication are immobility and intubation
External ophthalmoplegia means paralysis of the extraocular (extrinsic) muscles that move the eyes. Internal ophthalmoplegia means paralysis of the intrinsic (internal) eye muscles that control pupil size and accommodation (focusing).
Characteristics of GBS (AIDP)
Acute idiopathic demyelinating polyradiculoneuropathy
- Characterised by ascending symmetrical flaccid paralysis with areflexia
- Albuminocytologic dissociation, characterised by elevated protein levels and normal cell count in CSF
Cause of GBS
- Occur usually 4 weeks after an upper respiratory tract infection or GIT infection
- Most commonly associated with campylobacter jejuni + CMV
Other causes include: - Bacterial: Mycoplasma pneumoniae Viral: CMV, Zika virus, EBV, HIV, influenza, covid 19 - ZIKA - 2 weeks post COVID 18 - Post immune checkpoint inhibitors - ?vaccinations
Pathophysiology of GBS
Humorally mediated rather than T cells
- Postinfectious autoimmune reaction that generates cross-reactive antibodies (molecular mimicry)
- Infection triggers humoral response → formation of autoantibodies against gangliosides (e.g., GM1, GD1a) or other unknown antigens of peripheral Schwann cells → immune-mediated segmental demyelination → axonal degeneration of motor and sensory fibers in peripheral and cranial nerves (CN III–XII)
Clinical features of GBS
- Symmetrical ascending flaccid paralysis
- Reduced/absent reflexes
- Autonomic dysfunction: arrhythmia, void dysfunction, intestinal dysfunction,, postural hypotension
Autonomic symptoms are common in GBS. The most frequently encountered are tachycardia and urinary retention. Although autonomic dysfunction may manifest as hypertension, hypotension, bradycardia, or ileus, these are not as commonly seen. - Respiratory muscle involvement
- Sensory deficit rare
- Lower back pain
- Symptoms peak at 4 weeks
Subtypes and variants of GBS
- AIDP
- acute variant
- Associated with campylobacter jejuni + CMV
- Ascending flaccid paralysis, autonomic neuropathy, peak at 4 weeks
- IVIG, plasmapheresis - CIDP
- Chronic variant > 8 weeks
- Sensory symptoms and proximal weakness more common - proximal and distal weakness
- Reduced reflexes
- Milder phenotype, rarely have resp involvement/intubation
- Anti-GM1 ganglioside autoantibodies
- Clinical features > 8 weeks
- Glucocorticoids, azathioprine, cyclophosphamide, plasmapharesis, IVIG, ritux for Ab positive disease (better outcomes with early treatment) - Miller Fisher syndrome
- Limited variant of GBS characterised by cranial nerve involvement
- Autoantibodies directed against ganglioside Gq1b, GTa
- Ophthalmoplegia, ataxia, areflexia
- IVIG - Multifocal motor neuropathy (MMN)
- Variant of GBS affecting the motor neurons - asymmetric pure motor weakness
- Onset is usually in the upper extremities
- DDx for AML
- Anti- GM1 ganglioside autoantibodies
- Usually normal protein levels in CSF
- Asymmetric paralysis and areflexia
Deep tendon reflexes are usually decreased but typically intact in unaffected areas
- IVIG
- Steroids can worsen condition. - Acute motor axonal neuropathy
- Abrupt onset variant of GBS
- Affects motor nerve fibres with variable severity and spares sensory fibres
- Typically occurs after campylobacter jejuni, against GM1 ganglioside like epitopes
- Acute paralysis
- Areflexia without sensory loss
- IVIG, plasmapheresis
Ix for GBS
Bloods
- Elevated LFT in 30%
- Elevated CK
- Serology for C jejuni, HIV, CMV, EBV
CSF
- Albuminocytologic dissociation, high protein levels and normal cell count
- Elevation may be delayed it taken too early
Forced vital capacity, <1L = ICU
NCS
- Decreased nerve conduction velocity due to demyelination /conduction block
- Prolonged F wave latency
EMG: denervation, demyelinating pattern
ECG: autonomic cardiac dysregulation - impaired heart frequency variation